trending Market Intelligence /marketintelligence/en/news-insights/trending/iD9QEVKPn5saGK1Y-uukiw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Sorrento stocks soar as company discloses acquisition offer from PE fund

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Sorrento stocks soar as company discloses acquisition offer from PE fund

Sorrento Therapeutics Inc. said it received a nonbinding offer from a private equity fund to acquire a majority or all of the issued and outstanding shares of the company for up to $7 per share.

The San Diego-based biotechnology company's stock was up by 46.33% to $4.99 in pre-market trading Jan. 10 on Nasdaq.

The company did not disclose the name of the interested party.

According to a report from Reuters, the proposed offer values the company at about $993 million. Sorrento's market capitalization stood at about $483.8 million at the close of Jan. 9.

Sorrento said the company was reviewing the proposal, which was received Jan. 9, though there was no guarantee that a transaction will take place.

In November 2019, Sorrento rejected an unsolicited offer from two unnamed biopharmaceutical companies who were seeking to acquire the company for between $3 and $5 per share in cash.